-+ 0.00%
-+ 0.00%
-+ 0.00%

ABBISKO THERAPEUTICS’ CSF-1R INHIBITOR PIMICOTINIB APPROVED BY THE CHINA NMPA, ADDRESSING THE TREATMENT GAP FOR TENOSYNOVIAL GIANT CELL TUMOR

路透·12/22/2025 11:30:02

登录查看新闻详情